Cargando…
South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan
Ramadan is a lunar based month, during which Muslims across the world observe the ritual fast. This provides a challenge not only to the diabetic patient who wishes to observe the fast but also to the health care professional managing his diabetes. The challenge is to use therapies which are effecti...
Autores principales: | Pathan, Md Faruque, Sahay, Rakesh Kumar, Zargar, Abdul Hamid, Raza, Syed Abbas, Khan, A. K. Azad, Siddiqui, Nazrul Islam, Amin, Firoz, Kalra, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401750/ https://www.ncbi.nlm.nih.gov/pubmed/22837910 http://dx.doi.org/10.4103/2230-8210.98003 |
Ejemplares similares
-
South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan
por: Pathan, Md Faruque, et al.
Publicado: (2012) -
Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan
por: Bashir, Mir Iftikhar, et al.
Publicado: (2012) -
Thyroid diseases and Ramadan
por: Raza, Syed A., et al.
Publicado: (2012) -
Guidelines regarding management of adrenal insufficiency in the Holy month of Ramadan
por: Siddiqi, Sheelu S., et al.
Publicado: (2012) -
Diabetic emergencies including hypoglycemia during Ramadan
por: Ahmad, Jamal, et al.
Publicado: (2012)